Chronic HMG-CoA Reductase Inhibitor Treatment Contributes to Dysglycemia by Up-Regulating Hepatic Gluconeogenesis through Autophagy Induction

被引：0
作者：
Wang, Hye Jin
Park, Jae Yeo
Choe, Eun Yeong
Kwon, Obin
Lee, Yong-Ho
Kim, Gyuri
Bae, Jaehyun
Park, Se Hee
Yun, Yu Jung
Yun, Mijin
Kim, Chul Hoon
Lee, Hyangkyu
Kim, Young Bum
Kang, Eun Seok
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1787-P
引用
收藏
页码：A461 / A461
页数：1
相关论文
共 50 条
[1]   Chronic HMGCR/HMG-CoA reductase inhibitor treatment contributes to dysglycemia by upregulating hepatic gluconeogenesis through autophagy induction [J].
Wang, Hye Jin ;
Park, Jae Yeo ;
Kwon, Obin ;
Choe, Eun Yeong ;
Kim, Chul Hoon ;
Hur, Kyu Yeon ;
Lee, Myung-Shik ;
Yun, Mijin ;
Cha, Bong Soo ;
Kim, Young-Bum ;
Lee, Hyangkyu ;
Kang, Eun Seok .
AUTOPHAGY, 2015, 11 (11) :2089-2101
[2]   Chronic HMG-Co Reductase Inhibitor (Statin) Treatment Contributes to Dysglycemia by Upregulating Hepatic Gluconeognesis via Autophagy Induction [J].
Wang, Hye Jin ;
Park, Jae Yeo ;
Choe, Eun Yeong ;
Kwon, Obin ;
Jeon, Jeong Yong ;
Cho, Yongin ;
Yun, Yu Jung ;
Kim, Chul Hoon ;
Yun, Mijin ;
Lee, Byung-Wan ;
Cha, Bong Soo ;
Lee, Hyun Chul ;
Lee, Hangkyu ;
Kang, Eun Seok .
DIABETES, 2013, 62 :A483-A483
[3]   HMG-CoA reductase inhibitor treatment in renal insufficiency [J].
Wanner, C .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (10) :1951-1952
[4]   HYPERKALEMIA DURING TREATMENT WITH HMG-COA REDUCTASE INHIBITOR [J].
EDELMAN, S ;
WITZTUM, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (18) :1219-1220
[5]   Chronic creatine kinase elevation not associated with HMG-CoA reductase inhibitor treatment [J].
Lin, JC ;
Ito, MK .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (02) :163-166
[6]   HYPERKALEMIA DURING TREATMENT WITH HMG-COA REDUCTASE INHIBITOR - REPLY [J].
GRUNDY, SM .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (18) :1220-1220
[7]   Pitavastatin A New HMG-CoA Reductase Inhibitor for the Treatment of Hypercholesterolemia [J].
Ahmad, Haniyyah ;
Cheng-Lai, Angela .
CARDIOLOGY IN REVIEW, 2010, 18 (05) :264-267
[8]   FOCUS ON PRAVASTATIN - AN HMG-COA REDUCTASE INHIBITOR FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA [J].
BROISMAN, L ;
ENGSTER, P ;
CHOW, MSS .
HOSPITAL FORMULARY, 1991, 26 (07) :552-563
[9]   Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine [J].
Yang, BB ;
Hounslow, NJ ;
Sedman, AJ ;
Forgue, ST .
JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (04) :356-360
[10]   FOCUS ON SIMVASTATIN - A POTENT HMG-COA REDUCTASE INHIBITOR FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA [J].
QUERCIA, RA .
HOSPITAL FORMULARY, 1989, 24 (10) :559-&
12345